# Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/fees-for-human-drug-compounding-outsourcing-facilities-under-sections-503b-and-744k-of-the-fdc-act/56f9622b-7869-4157-b784-d3446072e7da

> FDA guidance document: Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act. Issue date: April 03, 2020. Get complete insights and analysis.

---

## Details

- Title: Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2020-04-03
- Last Changed: 2020-04-03
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2014-D-0329">FDA-2014-D-0329</a>

## Related Documents

- [Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling-Final](https://www.globalkeysolutions.net/guidances/guidance-document/product-name-placement-size-and-prominence-in-advertising-and-promotional-labeling-final/fa68136f-ad70-49ea-a8cd-cc47e646f4a1)
- [Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/adverse-event-reporting-for-outsourcing-facilities-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/4c23f98f-eaf3-4ed1-8f57-33ea6ba03529)
- [Registration for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/registration-for-human-drug-compounding-outsourcing-facilities-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/74d2bf28-3d33-408f-9b37-e47a144fa9bc)